Coherus Oncology (CHRS) Revenue (2013 - 2026)
Coherus Oncology's Revenue came in at $14.31 million for Q2 2026, up 39.5% from $10.25 million a year earlier and up 16.2% from the prior quarter.
Powered by 
Analysis
Coherus Oncology (CHRS) Revenue (2013 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Coherus Oncology reported Revenue of $50.94 million, up 61.0% year-over-year; for FY2025, it came in at $42.17 million, up 59.8% from FY2024.
- Revenue carries a five-year compound annual growth rate of -38.4% (FY2020 to FY2025).
- Going back by year, Revenue was $26.39 million in FY2024 (-89.7%), $257.24 million in FY2023 (+21.9%), $211.04 million in FY2022 (-35.4%) and $326.55 million in FY2021 (-31.4%).
- The Q2 2026 figure represents the highest quarterly Revenue since Q4 2023.
- Year-over-year, Revenue has increased for four consecutive quarters, with growth averaging 37.9% over the last eight quarters.
- The fastest year-over-year change in Revenue over five years came in Q1 2025 (growth of 229.2%), and the weakest in Q1 2024 (a decline of 92.9%).
- Business Quant data shows CHRS's Revenue at $12.31 million (Q1 2026), $12.75 million (Q4 2025) and $11.57 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,194.16 Bn | 1,167.78 Bn | 20.46 Bn | 24.40 Bn |
| 2 | Johnson & Johnson | 641.97 Bn | 561.83 Bn | 17.30 Bn | 25.40 Bn |
| 3 | AbbVie | 497.97 Bn | 465.98 Bn | 13.12 Bn | 17.40 Bn |
| 4 | Merck | 354.84 Bn | 317.78 Bn | 13.19 Bn | 18.09 Bn |
| 5 | Novartis Ag | 309.79 Bn | 283.03 Bn | - | - |
| 6 | Astrazeneca | 283.31 Bn | 257.20 Bn | 13.26 Bn | 15.07 Bn |
| 7 | Amgen | 243.18 Bn | 194.84 Bn | 7.58 Bn | 10.37 Bn |
| 8 | Gilead Sciences | 204.92 Bn | 180.03 Bn | 6.73 Bn | 8.30 Bn |
| 9 | Pfizer | 163.45 Bn | 110.81 Bn | 12.56 Bn | 16.58 Bn |
| 10 | Coherus Oncology | 115.82 Mn | -520.32 Mn | 10.07 Mn | 14.31 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 14.31 Mn |
| Mar 31, 2026 | 12.31 Mn |
| Dec 31, 2025 | 12.75 Mn |
| Sep 30, 2025 | 11.57 Mn |
| Jun 30, 2025 | 10.25 Mn |
| Mar 31, 2025 | 7.60 Mn |
| Dec 31, 2024 | 7.73 Mn |
| Sep 30, 2024 | 6.05 Mn |
| Jun 30, 2024 | 10.30 Mn |
| Mar 31, 2024 | 2.31 Mn |
| Dec 31, 2023 | 91.52 Mn |
| Sep 30, 2023 | 74.57 Mn |
| Jun 30, 2023 | 58.72 Mn |
| Mar 31, 2023 | 32.44 Mn |
| Dec 31, 2022 | 45.35 Mn |
| Sep 30, 2022 | 45.42 Mn |
| Jun 30, 2022 | 60.15 Mn |
| Mar 31, 2022 | 60.12 Mn |
| Dec 31, 2021 | 73.35 Mn |
| Sep 30, 2021 | 82.50 Mn |
API Access
Coherus Oncology Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=CHRS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "CHRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=CHRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();